Daily Filing Digest — 18 Sep 2026

Vedanta Resources just released encumbrances covering more than half of Vedanta Limited's entire share capital — the payoff of fully repaying $1.1 billion in guaranteed bonds. Elsewhere: a home-retail company's auditor flagged going-concern doubt over a negative net worth, an NBFC arm of a fintech lender lined up an ₹832 crore capital raise, and a scrap of Q1 FY27 results from three weeks ago turned out to carry today's real story.

The one to read first

EID Parry's consolidated profit of ₹142 crore this quarter came almost entirely from Coromandel International, its separately-listed farm-inputs subsidiary — the standalone entity that actually trades as EIDPARRY posted an operating loss. Today's companion piece: EID Parry's Consolidated Profit Was ₹142 Crore. Its Own Standalone Business Lost Money.

Capital structure and ownership

Vedanta Resources disclosed the release of encumbrances over 2,030,794,344 Vedanta Limited shares — 51.93% of the company's total share capital — held by three Vedanta Resources subsidiaries, effective 17 September. The encumbrance existed as a bond-covenant restriction tied to $1.1 billion in guaranteed senior bonds (two $550 million tranches at 9.475% and 9.85%); with those bonds fully repaid and settled, the restriction is released. Not a pledge for a loan in the everyday sense, but a real deleveraging signal at the promoter-group level nonetheless.

Deals and capital actions

Kissht (OnEMI Technology Solutions) secured board approval for a ~₹832 crore preferential equity raise, with 75% earmarked for its wholly owned NBFC subsidiary Si Creva Capital Services to scale lending operations.

Rosstech Elastomers approved a ₹300 crore preferential issue of shares at ₹1,166 each to SBI Mutual Fund and SBI Optimal Equity Fund — both qualified institutional buyers, non-promoter — subject to shareholder approval at an EGM convened for 15 October.

QMS Medical Allied Services completed its acquisition of the remaining 24% of Saarathi Healthcare for ₹14.225 crore, making it a wholly owned subsidiary — a routine step-up from an existing 76% holding.

Order wins

• Highway Infrastructure: ₹220.66 crore toll collection contract from UPEIDA on the Gorakhpur Link Expressway, an initial two-year term extendable by up to six months.
• Cryogenic OGS: an export purchase order worth USD 2.02 million (~₹19.36 crore) for piping spools, described by the company as its first independent export order in that vertical.

The going-concern cluster

Praxis Home Retail filed Q1 FY27 results (revenue ₹2,660.07 lakh, loss after tax ₹1,106.49 lakh) in which the auditor flagged material going-concern uncertainty — negative net worth of ₹8,817.97 lakh, current liabilities exceeding current assets by ₹6,910.97 lakh, and a notice under the Insolvency and Bankruptcy Code from an operational creditor, on top of pending contingent lease/credit claims.

TV Vision informed exchanges that its Committee of Creditors held its first meeting on 31 August, approving an IBBI-registered resolution professional — confirming the company remains under Corporate Insolvency Resolution Process. Supreme Engineering and Microse India both filed results disclosing negative net worth alongside NPA/statutory-compliance failures. Satiate Agri, also under CIRP, convened its own first Committee of Creditors meeting for 21 September.

What we're not reporting

Two promoter-side pledge actions cleared today's sweep without carrying enough size to warrant individual lines — a release at Ajanta Pharma and a fresh pledge at Eureka Forbes — alongside several routine NCLT scheme sanctions and voting-result filings. Rajesh Infra & Realty's board meeting notice on an NCLT-approved resolution plan (extinguishment and reconstitution of shares) is procedural at this stage — no operating or competitive detail is yet stated. No credit-rating downgrade, qualified/adverse audit opinion, or unreadable document was found in today's sweep.

Educational research, not investment advice. Every figure above is drawn from the named company's own primary filing dated 18 September 2026 and checked against the source. No buy/sell recommendations, no price targets. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.